IndraLab
Statements
sparser
"Sodium channel Nav1.7 has emerged as a target of considerable interest in pain research, since loss-of-function mutations in SCN9A , the gene that encodes Nav1.7, are associated with a syndrome of congenital insensitivity to pain, gain-of-function mutations are linked to the debiliting chronic pain conditions erythromelalgia and paroxysmal extreme pain disorder, and upregulated expression of Nav1.7 accompanies pain in diabetes and inflammation."
sparser
"In particular, Nav1.7 has recently emerged as a target of considerable interest, since loss-of-function mutations in SCN9A , the gene that encodes Nav1.7, are associated with congenital insensitivity to pain [ xref - xref ] and gain-of-function mutations have been linked to pain in erythromelalgia [ xref - xref ] and paroxysmal extreme pain disorder (PEPD) [ xref - xref ]."